4.7 Review

Application of Mesenchymal Stem Cells in Inflammatory and Fibrotic Diseases

Journal

Publisher

MDPI
DOI: 10.3390/ijms21218366

Keywords

mesenchymal stem cells (MSCs); paracrine factors; inflammatory disease; fibrotic disease

Funding

  1. National Research Foundation of Korea (NRF) - Korean government (MSIT) [2019R1F1A1058107]
  2. Next Generation BioGreen 21 program (System and Synthetic Agrobiotech Center), Republic of Korea [PJ01342101]
  3. National Research Foundation of Korea [2019R1F1A1058107] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Mesenchymal stem cells (MSCs) are multipotent stem cells that can be isolated from various tissues in the adult body. MSCs should be characterized by three criteria for regenerative medicine. MSCs must (1) adhere to plastic surfaces, (2) express specific surface antigens, and (3) differentiate into mesodermal lineages, including chondrocytes, osteoblasts, and adipocytes, in vitro. Interestingly, MSCs have immunomodulatory features and secrete trophic factors and immune receptors that regulate the microenvironment in host tissue. These specific and unique therapeutic properties make MSCs ideal as therapeutic agents in vivo. Specifically, pre-clinical and clinical investigators generated inflammatory and fibrotic diseases models, and then transplantation of MSCs into diseases models for therapeutic effects investigation. In this review, we characterize MSCs from various tissues and describe their applications for treating various inflammation and fibrotic diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available